Antibiotic Developer Tetraphase Prices Initial Public Offering
BioWorld Insight Editor
Antibiotic drug developer Tetraphase Pharmaceuticals Inc., of Watertown, Mass., joined recent publicly listed antibiotic-focused biotechnology companies Trius Therapeutics Inc. (2010) and Cempra Inc. (2012) by pricing its initial public offering (IPO) Wednesday.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST